Rosati, G.; Cordio, S.; Reggiardo, G.; Aprile, G.; Butera, A.; Avallone, A.; Tucci, A.; Novello, G.; Blanco, G.; Caputo, G.;
et al. Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials. Cancers 2019, 11, 578.
https://doi.org/10.3390/cancers11040578
AMA Style
Rosati G, Cordio S, Reggiardo G, Aprile G, Butera A, Avallone A, Tucci A, Novello G, Blanco G, Caputo G,
et al. Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials. Cancers. 2019; 11(4):578.
https://doi.org/10.3390/cancers11040578
Chicago/Turabian Style
Rosati, Gerardo, Stefano Cordio, Giorgio Reggiardo, Giuseppe Aprile, Alfredo Butera, Antonio Avallone, Aniello Tucci, Giuseppe Novello, Giuseppina Blanco, Giuseppe Caputo,
and et al. 2019. "Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials" Cancers 11, no. 4: 578.
https://doi.org/10.3390/cancers11040578
APA Style
Rosati, G., Cordio, S., Reggiardo, G., Aprile, G., Butera, A., Avallone, A., Tucci, A., Novello, G., Blanco, G., Caputo, G., Bilancia, D., & Bordonaro, R.
(2019). Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials. Cancers, 11(4), 578.
https://doi.org/10.3390/cancers11040578